# Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)

> **NCT00716742** · — · COMPLETED · sponsor: **Allergan** · enrollment: 1099 (actual)

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004%

## Key facts

- **NCT ID:** NCT00716742
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-09
- **Final completion:** 2009-09
- **Target enrollment:** 1099 (ACTUAL)
- **Last updated:** 2012-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00716742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00716742, "Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00716742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*